Sanofi to cut U.S. insulin costs for some patients to $99 per month

Sanofi SA said on Wednesday it will cut the cost of its insulin products to $99 per month for uninsured patients and others who pay cash for it in the United States, as the French drugmaker contends with intense criticism over the high price of the life-sustaining diabetes medication.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Date: Monday, 04 22, 2019; Speaker: Miranda Broadney , Using FreeStyle Libre Pro Continuous Glucose Monitor in youth , The Yanovski group, DTM, NICHD; Younghoon Jang, Transcriptional regulation of post-natal adipose tissue development, The Ge group, CEB, NIDDK; Building: Building 10 (Clinical Center); Solarium Conference Room 9S233 (old Bunim Room)
Source: NIH Calendar of Events - Category: American Health Source Type: events
Conclusions We found significantly decreased kidney concentrating ability in the long-term lithium-treated patients compared with the control group. Other renal function markers did not indicate any significant signs of renal dysfunction.
Source: Journal of Clinical Psychopharmacology - Category: Psychiatry Tags: Original Contributions Source Type: research
Authors: Tanimura J, Nakagawa H, Tanaka T, Kikuchi A, Osada S, Tanaka Y, Tokuyama K, Takamura T Abstract The mechanistic target of rapamycin (mTOR) inhibitor everolimus is an antitumor agent known to cause hyperglycemia. However, the clinical course of everolimus-induced hyperglycemia, its pathophysiological basis, and the treatment strategy are not clear. In this case series report, we present the clinical course of everolimus-induced hyperglycemia in four patients. Hyperglycemia occurred 3-8 weeks after the administration of everolimus irrespective of the body mass index (range, 21.3-29.1 kg/m2) or pre-existing d...
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
Publication date: Available online 15 April 2019Source: Food Research InternationalAuthor(s): Vítor Spínola, Joana Pinto, Eulogio J. Llorent-Martínez, Paula C. CastilhoAbstractIn this work, the phenolic composition of E. umbellata leaves and berries is reported. Berries were rich in flavonols, whereas leaves presented abundant flavonols and ellagitannins. Then, the enzyme-inhibitory properties, anti-glycation and antioxidant activities of E. umbellata and Sambucus lanceolata (its phenolic profile has been already established in a previous work) were tested by several in vitro assays and compared. The s...
Source: Food Research International - Category: Food Science Source Type: research
Authors: Lawton J, Blackburn M, Rankin D, Werner C, Farrington C, Hovorka R, Hallowell N Abstract Increasing ethical attention and debate is focusing on whether individuals who take part in clinical trials should be given access to post-trial care. However, the main focus of this debate has been upon drug trials undertaken in low-income settings. To broaden this debate, we report findings from interviews with individuals (n = 24) who participated in a clinical trial of a closed-loop system, which is a medical device under development for people with type 1 diabetes that automatically adjusts blood glu...
Source: AJOB Primary Research - Category: Medical Ethics Tags: AJOB Empir Bioeth Source Type: research
Publication date: Available online 15 April 2019Source: Journal of Environmental Chemical EngineeringAuthor(s): Vijay Kumar, Simranjeet Singh, Bhavana Srivastava, Ragini Bhadouria, Ravindra SinghAbstractIn present study, silver nanoparticles (AgNPs) were synthesized from the aqueous extract of Holoptelea integrifolia (HI) leaves and characterized by UV-Visible spectroscopy, Fourier transformation infrared spectroscopy (FTIR), field emission scan electron microscopy (FESEM), electron disperse X-ray (EDX) and X-ray diffraction (XRD) analysis. UV-visible study confirmed the formation of AgNPs. FTIR studies confirmed the prese...
Source: Journal of Environmental Chemical Engineering - Category: Chemistry Source Type: research
CONCLUSIONS: We expected to provide scientific evidence on the effectiveness of health counselling. PMID: 30982808 [PubMed - as supplied by publisher]
Source: Journal of Epidemiology - Category: Epidemiology Tags: J Epidemiol Source Type: research
Publication date: Available online 15 April 2019Source: Progress in Retinal and Eye ResearchAuthor(s): Einar Stefánsson, Olof Birna Olafsdottir, Thorunn S. Eliasdottir, Wouter Wehmeijer, Anna Bryndis Einarsdottir, Toke Bek, Thomas Lee Torp, Jakob Grauslund, Thor Eysteinsson, Robert Arnar Karlsson, Karel Van Keer, Ingeborg Stalmans, Evelien Vandewalle, Margarita G. Todorova, Martin Hammer, Gerhard Garhöfer, Leopold Schmetterer, Martin Šín, Sveinn Hakon HardarsonAbstractRetinal oximetry imaging of retinal blood vessels measures oxygen saturation of hemoglobin. The imaging technology is non-invasive ...
Source: Progress in Retinal and Eye Research - Category: Opthalmology Source Type: research
Publication date: Available online 15 April 2019Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Qiao Wen, Zhiwei Zhao, Jirui Wen, Jing Zhou, Jiang Wu, Sun Lei, Yali MiaoAbstractBackgroundRecently, metformin, first-line drug for type 2 diabetes, has been reported to treat some gynecological tumors. However, these epidemiological studies have never been formally summarized. Considering a single study may lack the power to provide reliable conclusion, we performed two meta-analyses with different indicators to assess metformin’s role in reducing the risk of gynecological cancers...
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Diabetes | Endocrinology | France Health | Health | Insulin | Uninsured | USA Health